There are 1,710 papers on albumin in aging research: 103 trials and 1,441 observational studies in people, 59 in animals, 4 in cells, 86 reviews.
220 new papers in 30 daysSee all 3,488 papers on albumin
At a glance
Higher albumin is associated with lower mortality in older patients with pneumonia or receiving peritoneal dialysis, and with less frailty in geriatric inpatients. An observational study of surgically treated intertrochanteric fractures shows no clear link with one-year mortality. Human trials report albumin increases with nutritional support or resistance training, but no clear change with beta-hydroxy-beta-methylbutyrate.
326 findings in 294 papers from 2002 to 2026, 49 of them since April 2026
“Mortality at 180 days was significantly increased in the low albumin group compared with patients with normal albumin concentrations”
- Human trial103
- Humans1,441
- Animals59
- Cells4
- In silico6
Interventions
38Omega-3 fatty acids
upin humans2no changein humans1
3 studies
Omega-3 fatty acids
upin humans2no changein humans1
Omega-3 fatty acids increase albumin in patients with CKD undergoing hemodialysis (p = 0.014).
“However, group that received w-3 showed an improvement in serum albumin levels (p = 0.014)”
Human trialin patients with CKD undergoing hemodialysiscapsules2g/day8 weeksn = 59
Clinical nutrition ESPEN
Omega-3 fatty acids increase albumin in humans (hemodialysis) (P = 0.07).
“For the omega-3 group, serum albumin was also marginally higher after 6 months as compared to baseline (P = 0.07).”
Human trialhemodialysisplasma-serum2.4 g omega-3 plus 30 mL protein6 months
Vascular health and risk management
Omega-3 fatty acids showed no clear effect on albumin in humans (patients on hemodialysis) (SMD 0.91 (95% CI -0.78, 2.59)).
“but did not significantly improve albumin (SMD: 0.91; 95% CI: -0.78, 2.59)”
Reviewpatients on hemodialysissupplementationn = 371
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
Caloric restriction
downin humans1downin mice1
2 studies
Caloric restriction
downin humans1downin mice1
Caloric restriction decreases albumin in humans (-8.6% vs -14.8%).
“Albumin decreased by 8.6% in the CR group and 14.8% in the CR + Ex group (p ≤ 0.001”
Human trial6-monthfemalesn = 102
The journal of nutrition, health & aging
Caloric restriction decreases albumin in humans (inactive overweight or obese) (from 63.26 ± 51.08 to 56.43 ± 37.38 g/dL).
“albumin (from 63.26 ± 51.08 to 56.43 ± 37.38 g/dL)”
Human trialinactive overweight or obese6-monthfemalesn = 102
The journal of nutrition, health & aging
Caloric restriction decreases albumin in mice (60% dietary restriction).
“The present animal model also showed biochemical changes with hypoalbuminemia”
Animals60% dietary restriction10 weeksmales
The Journal of nutritional biochemistry
Resistance training
upin humans2
2 studies
Resistance training
upin humans2
Resistance training increases albumin in humans.
“albumin (F = 7.214, P =.003; 4 weeks > baseline [Group RT+WP, Group RT+placebo]; 8 weeks > baseline [Group RT+WP, Group RT+placebo]; 8 weeks > 4 weeks [Group RT+WP, Group RT+placebo]; Group RT+WP > Group RT+placebo [8 weeks”
Human trial8 weeksn = 28
Medicine
Resistance training increases albumin in IBD patients with sarcopenia (F = 7.214, P = .003).
“Both interventions significantly increased albumin (F = 7.214, P = .003).”
Human trialin IBD patients with sarcopenia8 weeks
Medicine
Resistance training increases albumin in maintenance hemodialysis patients (MD = 3.16, 95% CI [1.13-5.19]).
“serum albumin level (MD = 3.16, 95% CI [1.13-5.19]; P = 0.002) compared with the controls”
Reviewin maintenance hemodialysis patientsn = 541
PeerJ
Beta-hydroxy-beta-methylbutyrate
upin humans1no changein humans1
2 studies
Beta-hydroxy-beta-methylbutyrate
upin humans1no changein humans1
Beta-hydroxy-beta-methylbutyrate increases albumin in humans (combined with multicomponent exercise training in older adults with frailty).
“After 4 weeks, the intervention group showed significantly better total SPPB score, balance score, 6MWT performance, MBI score, and serum albumin level than the control group did (all P < 0.05).”
Human trialcombined with multicomponent exercise training in older adults with frailtycalcium HMB3 g/d12 weeksn = 136
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Beta-hydroxy-beta-methylbutyrate showed no clear effect on albumin in humans.
“Statistically significant differences were not observed in the nutritional indicators albumin and prealbumin between the groups, or before and after the intervention (P > 0.05), as demonstrated in Table.”
Human trialn = 78
Aging clinical and experimental research
Sequential enteral nutrition support
upin humans1
1 study
Sequential enteral nutrition support
upin humans1
Sequential enteral nutrition support increases albumin in humans (Δ difference = 4.43 g/L).
“Compared to the control group, the intervention group had higher levels of ALB (Δ difference = 4.43 g/L), PA (Δ difference = 65.42 mg/L), Hb (Δ difference = 22.67 g/L) and TP (Δ difference = 3.35 g/L) 14 days after intervention”
Human trial14 days
Frontiers in medicine
Sequential enteral nutrition support increases albumin in humans (severe ischemic stroke after thrombectomy) (p < 0.05).
“higher levels of albumin (ALB), total protein (TP), prealbumin (PA), and hemoglobin (Hb) on the 14th day after intervention (p < 0.05)”
Human trialsevere ischemic stroke after thrombectomy14th dayn = 115
Frontiers in medicine
Multidisciplinary team nursing + high-fiber diet
upin humans1
1 study
Multidisciplinary team nursing + high-fiber diet
upin humans1
Multidisciplinary team nursing + high-fiber diet increases albumin in humans.
“Compared with the control group, the intervention group had higher ALB and TP levels (p < 0.05, ).”
Human trial8 weeks
Frontiers in medicine
Multidisciplinary team nursing + high-fiber diet increases albumin in humans (type 2 diabetes) (p < 0.05).
“the ALB and TP levels in the intervention group were higher (p < 0.05)”
Human trialtype 2 diabetes8 weeks
Frontiers in medicine
Exercise + nutritional care
upin humans1
1 study
Exercise + nutritional care
upin humans1
Exercise + nutritional care increases albumin in humans (41.80 ± 5.45 vs 32.25 ± 5.37 g/L).
“The home-based exercise combined with nutritional care intervention significantly improved key nutritional indicators in the observation group compared to the control group, including albumin, prealbumin, and transferrin levels.”
Human trial3 monthsn = 126
Frontiers in medicine
Exercise + nutritional care increases albumin in humans (gastric cancer and sarcopenia) (41.80 ± 5.45 g/L vs. 32.25 ± 5.37 g/L, t = 9.905).
“Following the intervention, the observation group exhibited significantly greater improvements in nutritional biomarkers compared to the control group: albumin (41.80 ± 5.45 g/L vs. 32.25 ± 5.37 g/L, t = 9.905, P < 0.001)”
Human trialgastric cancer and sarcopenian = 126
Frontiers in medicine
Mindfulness meditation + progressive muscle relaxation
upin humans1
1 study
Mindfulness meditation + progressive muscle relaxation
upin humans1
Mindfulness meditation + progressive muscle relaxation increases albumin in patients with sarcopenia receiving haemodialysis.
“When comparing the intervention with the control group, after 12 weeks, the intervention group showed improvements in physical abilities, KDQOLTM scores in the PF, RP, CH, Energy, SPL, SL, DSE, Pain, CF, EWB and PS dimensions, as well as serum inflammation indicators (hs-CRP, IL-1) and nutrition indicators (ALB and PA), and the improvements were significant compared to before the intervention (p < 0.05”
Human trialin patients with sarcopenia receiving haemodialysis12 weeksn = 49
BMC complementary medicine and therapies
Mindfulness meditation + progressive muscle relaxation increases albumin in humans (patients with sarcopenia receiving maintenance haemodialysis) (30.62 ± 1.65 vs 35.60 ± 1.68; 0.32 ± 0.05 vs 0.44 ± 0.07, p < 0.05).
“albumin and prealbumin levels were significantly increased compared with the baseline (30.62 ± 1.65 vs 35.60 ± 1.68; 0.32 ± 0.05 vs 0.44 ± 0.07) (p < 0.05)”
Human trialpatients with sarcopenia receiving maintenance haemodialysis12 weeks
BMC complementary medicine and therapies
More on Mindfulness meditation + progressive muscle relaxation
Multicomponent exercise + branched-chain amino acids
no changein humans1upin humans1
1 study
Multicomponent exercise + branched-chain amino acids
no changein humans1upin humans1
Multicomponent exercise + branched-chain amino acids showed no clear effect on albumin in humans.
“In terms of serum albumin, a statistically significant difference in the effect of time was found (F(df: 1949; 46,784) = 3.841, p = 0.02), but no other (time vs. group) significant difference was detected between the albumin levels (p = 0.219).”
Human trial40 weeksn = 50
Nutrients
Multicomponent exercise + branched-chain amino acids increase albumin in humans (frail older persons living at residential care homes).
“Improvement of cognitive profile and muscle strength-related albumin levels, as well as reduction in the TNF-α levels were found particularly in ME plus BCAAs group”
Human trialfrail older persons living at residential care homes40 weeksn = 8
Nutrients
More on Multicomponent exercise + branched-chain amino acids
Anticholinergic burden
downin humans1
1 study
Anticholinergic burden
downin humans1
Anticholinergic burden is linked with lower albumin in humans (high anticholinergic burden (ACB ≥ 2) vs controls (ACB = 0)) (4.08 ± 0.33 vs. 4.38 ± 0.27, p = 0.001).
“Serum albumin levels were lower in ACB patients comparing to controls (4.08 ± 0.33 vs. 4.38 ± 0.27, p = 0.001).”
Humanshigh anticholinergic burden (ACB ≥ 2) vs controls (ACB = 0)
Effect of anticholinergic burden on cardiac functions in older patients
Zeitschrift fur Gerontologie und Geriatrie
Individualized nutrition therapy
no changein humans1
1 study
Individualized nutrition therapy
no changein humans1
Individualized nutrition therapy showed no clear effect on albumin in humans (nursing home setting) (pre: 41.0 g/L post: 40.2 g/L, P =0.175).
“Serum albumin levels did not change throughout the intervention”
Human trialnursing home setting10 weeksn = 31
Clinical Nutrition Open Science
Combined aerobic and resistance training
no changein humans1
1 study
Combined aerobic and resistance training
no changein humans1
Combined aerobic and resistance training showed no clear effect on albumin in humans (type 2 diabetes without kidney disease).
“Urinary albumin changes did not differ between groups.”
Human trialtype 2 diabetes without kidney diseasekidney9 monthsn = 136
Diabetes & metabolic syndrome
Lifestyle modification
upin humans1
1 study
Lifestyle modification
upin humans1
Lifestyle modification increases albumin in humans.
“an increase in albumin, and the normalization of hematological parameters.”
Human trial6 monthsn = 100
CARDIOVASCULAR THERAPY AND PREVENTION
Gallic acid
upin humans1
1 study
Gallic acid
upin humans1
Gallic acid increases albumin in humans (especially in the trained obese group) (p = 0.043).
“an increase in albumin was identified in the supplement × time interaction (p = 0.043), especially in the trained obese group.”
Human trialespecially in the trained obese group200 mg/day12 weeks
Nutrients
Fracture liaison service
upin humans1
1 study
Fracture liaison service
upin humans1
Fracture liaison service increases albumin in humans (elderly hip fracture patients).
“the FLS group showed a significant increase in serum albumin over 1 year (P = 0.022).”
Human trialelderly hip fracture patients1 year
Clinical Outcomes of a Coordinator-Based Fracture Liaison Service for Hip Fractures in Korea
Journal of Korean medical science
All 38Fewer
Effects
18Mortality
mediatesin humans2downin humans1HR 0.52
3 studies
Mortality
mediatesin humans2downin humans1HR 0.52
Albumin is linked with less mortality in models including laboratory-defined diabetes (HR 0.52 per 1 g/dL, 95% CI 0.30-0.93).
“Higher serum albumin levels were independently protective in models including laboratory-defined diabetes (HR 0.52 per 1 g/dL, 95% CI 0.30-0.93)”
Humansin models including laboratory-defined diabetesn = 480
BMC cardiovascular disorders
Albumin is linked with mortality in humans (mediating effect of metformin on all-cause mortality) (13.32 %, P < 0.0001).
“relationship between metformin and all-cause mortality risk was partially mediated by ALB, accounting for 13.32 % of the association (P < 0.0001).”
Humansmediating effect of metformin on all-cause mortality
Diabetes research and clinical practice
Albumin is linked with mortality in humans (mediating the association between baseline physical activity and mortality) (proportion mediated 54%).
“Circulation levels of albumin and cholinesterase mediated the association between baseline PA and all-cause mortality (proportion mediated, 54%, both; p < 0.05).”
Humansmediating the association between baseline physical activity and mortality6-year follow-upn = 441
Physical activity and all-cause mortality and mediators of the association in the very old
Experimental gerontology
Sarcopenia
mediatesin humans1downin humans1
2 studies
Sarcopenia
mediatesin humans1downin humans1
Albumin is linked with sarcopenia in humans (PFAS-sarcopenia association) (3.48% to 82.42% proportion mediated).
“liver synthesis function markers (albumin and globin) mediated a substantial proportion of the association, ranging from 3.48% to 82.42%”
HumansPFAS-sarcopenia associationn = 1,261
Toxics
Albumin is linked with less sarcopenia in humans (independent association in binary logistic regression) (Exp(B) 0.490, 95% CI 0.281-0.853).
“Body mass index(BMI), albumin(ALB), fibroblast growth factor 19(FGF19), and tumour necrosis factor alpha(TNF-α) were independent protective factors for sarcopenia”
Humansindependent association in binary logistic regressionn = 236
Frontiers in endocrinology
Frailty
mediatesin humans2
2 studies
Frailty
mediatesin humans2
Albumin is linked with frailty in humans (asthma).
“The mediation analysis revealed that albumin and uric acid were mediators between the OBS and risk of frailty”
Humansasthman = 3,338
BMC pulmonary medicine
Albumin is linked with frailty in the relationship between DI-GM and frailty (30.34% of total effect).
“albumin and high-density lipoprotein (HDL) played significant mediating roles in the relationship between DI-GM and frailty, accounting for 30.34 and 9.05% of the total effect, respectively”
Humansin the relationship between DI-GM and frailty
The association between the dietary index for gut microbiota and frailty: a cross-sectional study
Frontiers in nutrition
Survival
downin humans1
1 study
Survival
downin humans1
Albumin is linked with lower survival in humans (patients undergoing percutaneous endoscopic gastrostomy) (40 days vs. 776 days (p < 0.001)).
“Patients with severe hypoalbuminemia (<2.0 g/dL) had a median survival of only 40 days, compared with 776 days in the highest albumin category (≥3.2 g/dL) (p < 0.001).”
Humanspatients undergoing percutaneous endoscopic gastrostomy
Clinical nutrition ESPEN
Waist circumference
mediatesin humans1
1 study
Waist circumference
mediatesin humans1
Albumin is linked with waist circumference in humans (vigorous physical activity and waist circumference) (ACME = 0.885, 95% CI: 0.596 to 1.187, P < 0.001).
“Mediation analysis showed a significant indirect effect through serum albumin (average causal mediation effect = 0.885, 95% confidence interval: 0.596 to 1.187, P < 0.001)”
Humansvigorous physical activity and waist circumferencen = 4,882
Research SquarePreprint
Incident respiratory disease
mediatesin humans1
1 study
Incident respiratory disease
mediatesin humans1
Albumin is linked with incident respiratory disease in humans (mediating the association of probable sarcopenia with incident respiratory disease) (2.6%–8.0% of association mediated).
“with C-reactive protein (5.2 %-12.9 %) and albumin (2.6%-8.0%) showing relatively higher mediation proportions”
Humansmediating the association of probable sarcopenia with incident respiratory diseasen = 317,628
The journal of nutrition, health & aging
Metabolic dysfunction-associated steatotic liver disease
mediatesin humans1
1 study
Metabolic dysfunction-associated steatotic liver disease
mediatesin humans1
Albumin is linked with metabolic dysfunction-associated steatotic liver disease in humans among SFA significantly associated with MASLD (5.9-8.0 %).
“serum albumin accounted for 5·9-8·0 %”
Humansamong SFA significantly associated with MASLD
The British journal of nutrition
More on Metabolic dysfunction-associated steatotic liver disease
Chronic obstructive pulmonary disease
mediatesin humans1
1 study
Chronic obstructive pulmonary disease
mediatesin humans1
Albumin is linked with chronic obstructive pulmonary disease in humans (Statistical mediation of the CKM-COPD association in the US cohort) (7.5% mediated; p < 0.001).
“Mediation analyses in the US cohort identified albumin as the strongest mediator (7.5%, p < 0.001)”
HumansStatistical mediation of the CKM-COPD association in the US cohort
Respiratory research
Handgrip strength reduction
downin humans1OR 0.714
1 study
Handgrip strength reduction
downin humans1OR 0.714
Albumin is linked with less handgrip strength reduction in humans (coronary artery disease) (OR 0.714, 95% CI 0.572-0.891).
“high albumin level (OR 0.714; 95%CI 0.572-0.891) were significantly and negatively associated with reduced handgrip strength”
Humanscoronary artery disease
Scientific reports
Cognitive function
mediatesin humans1
1 study
Cognitive function
mediatesin humans1
Albumin is linked with cognitive function in humans (relationship between selenium intake and cognition) (3.85% mediation proportion).
“Albumin and vitamin D significantly mediated the relationship between selenium intake and cognition, and the mediation proportion values of albumin and vitamin D were 3.85% and 8.02%, respectively.”
Humansrelationship between selenium intake and cognitionn = 2,154
Nutrients
All 18Fewer
Upstream
4Age
upin humans1downin rats1
2 studies
Age
upin humans1downin rats1
Age is linked with higher albumin in humans (older (63.0±4.0 years) versus younger (23.7±2.1 years) adults) (17.1%±12.4% versus 5.0%±9.6%).
“relative plasma-derived albumin levels were higher (17.1%±12.4%) in the tears of the older, compared with the younger (5.0%±9.6%) group.”
Humansolder (63.0±4.0 years) versus younger (23.7±2.1 years) adultstear filmn = 30
Clinical and biochemical analysis of the ageing tear film
The British journal of ophthalmology
age decreases albumin in rats.
“in contrast, albumin levels decreased”
Animalsmales
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering
Centenarians
upin humans1
1 study
Centenarians
upin humans1
Centenarians are linked with higher albumin in humans.
“Albumin was the most connected hub protein, notably elevated in centenarians compared to younger controls, suggesting a protective role.”
Humans
The 'autoimmunome' of centenarians
Journal of translational autoimmunity
CEBPB
downin human cells1
1 study
CEBPB
downin human cells1
CEBPB decreases albumin in HepG2 cells.
“The CEBP-β inhibition either by a functional inhibitor (i.e., quercetin) or shRNA silencing increased albumin mRNA in HepG2 cells.”
Cellsin HepG2 cells
Experimental cell research
IL10
downin human cells1
1 study
IL10
downin human cells1
IL10 decreases albumin in human cells.
“We found that IL-10, a paradoxical inflammaging marker, reduced ALB concentration in HepG2 cells.”
CellsHepG2 cells
Experimental cell research
Associations
126Mortality
downin humans35upin humans22HR 0.26–4.346
57 studies
Mortality
downin humans35upin humans22HR 0.26–4.346
Albumin raises the risk of mortality in humans (hospitalised medical patients at nutritional risk) (32.4% vs. 22.7%, HR 1.4, 95%CI 1.11 to 1.77, p = 0.005).
“Mortality at 180 days was significantly increased in the low albumin group compared with patients with normal albumin concentrations”
Human trialhospitalised medical patients at nutritional risk180 daysn = 1,389
EClinicalMedicine
Albumin is associated with mortality in humans (nontuberculous mycobacterial pulmonary disease; low albumin level; multivariate analysis) (Low albumin: HR 3.54, 95% CI 1.60–7.82).
“Smoking history and low albumin levels were associated with increased all-cause mortality in older adult patients with NTM-PD.”
Humansnontuberculous mycobacterial pulmonary disease; low albumin level; multivariate analysisn = 110
Lung India : official organ of Indian Chest Society
Albumin is associated with mortality in humans (proximal humerus fractures; multivariable Cox regression) (HR 0.26, 95% CI 0.15–0.45).
“Higher CCI, lower serum albumin, and lower platelet count were independently associated with mortality.”
Humansproximal humerus fractures; multivariable Cox regressionn = 261
Geriatric orthopaedic surgery & rehabilitation
Albumin is associated with mortality in humans (fragility fracture of the pelvis).
“Univariable analysis identified significant associations of age, the updated Charlson Comorbidity Index score, and serum albumin level with mortality.”
Humansfragility fracture of the pelvisn = 46
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
Albumin is linked with a lower risk of mortality in humans (from the frail state).
“higher albumin favored recovery from frailty and lowered the frail-to-death intensity”
Humansfrom the frail state
World Economy and Management research
Albumin is linked with a lower risk of mortality in humans (adults with depression) (HR 0.30 (95% CI 0.18–0.49)).
“each 1-unit increase in albumin level was associated with a HR of 0.30(95% CI,0.18–0.49, p < 0.001) for all-cause mortality”
Humansadults with depressioneach 1-unit increase89 monthsn = 2,410
Research SquarePreprint
Albumin predicts mortality in humans (HR 0.81 per 1 SD).
“albumin (0.81) carried most of the signal, with smaller contributions from cystatin C, ALT, NLR and hs-CRP”
Humansper 1 SDmedian 4.4 yearsn = 2,144
Research squarePreprint
Albumin predicts mortality in humans after low-energy femoral neck fracture surgery (58% increase in odds per 1 g/dL decrease).
“Each 1 g/dL decrease in albumin raised 5-year mortality odds by 58%.”
Humansafter low-energy femoral neck fracture surgeryeach 1 g/dL decreasen = 427
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
Albumin predicts mortality in humans (90-365 days post-hemiarthroplasty for hip fracture) (OR 0.92 per g/L).
“For 90-365 days, mortality was associated with age (OR 1.06), higher ASA score (OR 2.60), and lower albumin (OR 0.92 per g/L).”
Humans90-365 days post-hemiarthroplasty for hip fracture90-365 daysn = 433
Geriatric orthopaedic surgery & rehabilitation
Albumin is linked with a lower risk of mortality in humans (critical illness) (OR = .251, 95% CI = 0.111-0.565).
“serum albumin (odds ratio [OR] = .251, p =0.001, 95% confidence interval [CI] = 0.111-0.565)”
Humanscritical illnessn = 203
Electronic Journal of General Medicine
All 57Fewer
Frailty
downin humans27mixedin humans3upin humans1OR 0.17–0.95
31 studies
Frailty
downin humans27mixedin humans3upin humans1OR 0.17–0.95
Albumin is associated with frailty in humans (colorectal cancer patients admitted to the ICU after radical surgery).
“Higher albumin levels were a protective factor”
Humanscolorectal cancer patients admitted to the ICU after radical surgeryn = 308
Frontiers in oncology
Albumin is associated with frailty in humans (hospitalized heart failure patients) (aOR 0.92 per 1 g/L increase (95% CI, 0.87–0.97)).
“lower serum albumin (aOR, 0.92 per 1 g/L increase; 95% CI, 0.87–0.97)”
Humanshospitalized heart failure patientsn = 461
Research SquarePreprint
Albumin is associated with frailty in humans (active IBD) (OR 0.17, 95% CI 0.05-0.59).
“In multivariate analysis, shorter disease duration (OR = 0.83, 95% CI: 0.70-0.97, p = 0.021) and lower serum albumin levels (OR = 0.17, 95% CI: 0.05-0.59, p = 0.005) were independently associated with frailty”
Humansactive IBD
Medicina (Kaunas, Lithuania)
Albumin is associated with frailty in humans (maintenance hemodialysis).
“Increased age and low albumin level were identified as clinical correlates of frailty.”
Humansmaintenance hemodialysisn = 391
Frontiers in medicine
Albumin is associated with frailty in humans (Adjusted analysis) (OR 0.90, 95% CI 0.83–0.99).
“lower ALB levels (OR = 0.90, 95% CI: 0.83–0.99, P = 0.015)”
HumansAdjusted analysisn = 2,434
Scientific reports
Frailty is associated with albumin in adults with nondialysis chronic kidney disease.
“Laboratory findings associated with frailty included lower albumin and hemoglobin, higher blood urea nitrogen, lower bilirubin, reduced globulin, decreased lymphocyte count, and elevated monocyte count.”
Humansin adults with nondialysis chronic kidney disease
The Journal of international medical research
Albumin is associated with frailty in humans (chronic kidney disease on hemodialysis).
“it was found that there is indeed an association between frailty syndrome and albumin.”
Humanschronic kidney disease on hemodialysisn = 20
Lux Médica
Frailty is associated with albumin in cardiovascular patients (p < 0.05).
“Frail patients had significantly reduced serum albumin and increased fibrinogen compared to the prefrail and robust groups (p < 0.05).”
Humansin cardiovascular patientsn = 170
Nutrients
Albumin is associated with frailty in humans (pre-radiotherapy thoracic tumors).
“Elderly patients who were of advanced age, with multiple chronic diseases, taking multiple medications, engaging in limited resistance exercise, and having low albumin levels are especially vulnerable to frailty.”
Humanspre-radiotherapy thoracic tumorsn = 139
Pre-radiotherapy frailty and associated determinants in elderly patients with thoracic tumors
Translational cancer research
Frailty is associated with albumin in humans (inflammatory bowel disease).
“Frail individuals also exhibited lower hemoglobin, creatinine, and albumin levels.”
Humansinflammatory bowel disease53.5% females
Digestive diseases and sciences
All 31Fewer
Sarcopenia
downin humans12upin humans3OR 0.562–2.368
15 studies
Sarcopenia
downin humans12upin humans3OR 0.562–2.368
Albumin is associated with sarcopenia in humans (newly diagnosed, untreated hypothyroidism) (OR 0.562, 95% CI 0.390–0.809).
“albumin level (OR=0.562,95%CI 0.390-0.809) and FT3/FT4 ratio (OR=0.514,95%CI 0.360-0.734) were protective factors for sarcopenia (P<0.05).”
Humansnewly diagnosed, untreated hypothyroidismn = 147
Analysis of prevalence status and risk factors of sarcopenia in elderly patients with hypothyroidism
Chinese Journal of Multiple Organ Diseases in the Elderly
Albumin is linked with a lower risk of sarcopenia in humans (multivariate analysis) (OR 0.891, 95% CI 0.773-0.981).
“albumin (OR: 0.891, 95% CI: 0.773-0.981;p = 0.023) were independent predictors of sarcopenia”
Humansmultivariate analysisbloodfemalesn = 198
European Journal of Geriatrics and Gerontology
Albumin is associated with sarcopenia in humans (OR = 0.777, 95% Cl = 0.693-0.871).
“lower albumin (OR = 0.777, 95% Cl = 0.693-0.871) levels were associated with an increased risk of sarcopenia.”
Humansn = 396
Scandinavian journal of primary health care
Albumin is associated with sarcopenia in humans (maintenance hemodialysis patients) (PR = 1.80, 95% CI = 1.18-2.74).
“low serum albumin levels (<35 g/L; P = .007, PR = 1.80, 95% CI = 1.18-2.74)”
Humansmaintenance hemodialysis patientsn = 106
Medicine
Sarcopenia is associated with albumin in humans (inpatients with delirium) (p = 0.038).
“Sarcopenia was associated with lower albumin levels (p = 0.038)”
Humansinpatients with deliriumn = 57
Journal of clinical medicine
Sarcopenia is associated with albumin in hospitalized older adults.
“Serum hemoglobin and albumin levels were reduced in sarcopenic groups”
Humansin hospitalized older adultsbloodn = 598
Muscle or Heart? Functional Impact of Sarcopenia and Heart Failure in Geriatric Inpatients
Journal of clinical medicine
Sarcopenia is associated with albumin in older patients with chronic diseases.
“Serum irisin, 25(OH)D3, and albumin levels were significantly lower in sarcopenic patients.”
Humansin older patients with chronic diseases
Aging clinical and experimental research
Albumin is associated with sarcopenia in humans (Alzheimer's disease).
“Multivariate regression identified age, low Frailty Rating Scale (FRS) scores, low serum albumin level, and low creatinine/cystatin C ratio (CCR) as risk factors for sarcopenia.”
HumansAlzheimer's disease
Alzheimer's & dementia : the journal of the Alzheimer's Association
Sarcopenia is associated with albumin in humans (low skeletal muscle mass vs normal) (41.00 vs. 42.50 g/L, p < 0.001).
“These patients had lower albumin (41.00 vs. 42.50 g/L) and lymphocyte levels (1.60 vs. 2.02 × 109/L) but higher HDL (1.45 vs. 1.16 mmol/L) and calcium levels (2.24 vs. 2.20 mmol/L) (all p < 0.001).”
Humanslow skeletal muscle mass vs normaln = 1,002
Frontiers in nutrition
Albumin is associated with sarcopenia in humans (community-dwelling adults, adjusted for sociodemographic and other clinical factors) (OR 2.368 (95% CI 1.424-3.939), p < 0.001).
“having low albumin levels(≤ 4.0 g/dL) were independently associated with sarcopenia i.e. 2.368 times (95% CI 1.424-3.939) in males”
Humanscommunity-dwelling adults, adjusted for sociodemographic and other clinical factorsmalesn = 2,094
Serum albumin as a biomarker of (nutritional status in) sarcopenia
Journal of bone and mineral metabolism
All 15Fewer
1-year mortality
downin humans4upin humans2OR 0.39–0.81
6 studies
1-year mortality
downin humans4upin humans2OR 0.39–0.81
Albumin is associated with 1-year mortality in humans (Proximal femur fractures treated surgically; mutually exclusive adjusted regression models).
“higher NLR and D-dimer levels, lower albumin levels, and a higher composite score were associated with 1-year mortality.”
HumansProximal femur fractures treated surgically; mutually exclusive adjusted regression models1 yearn = 300
Archives of orthopaedic and trauma surgery
Albumin is associated with 1-year mortality in humans (OR per 1-g/dL 0.27).
“and albumin concentration (OR per 1-g/dL 0.27).”
Humans
Circulation reports
Albumin is linked with a lower risk of 1-year mortality in humans following hip fracture surgery, admission (OR 0.81, 95% CI 0.75-0.87).
“albumin (OR 0.81, 95% CI [0.75-0.87]), values at admission were found to be independent predictors of 1-year mortality in elderly patients with hip fracture.”
Humansfollowing hip fracture surgery, admission
Predictors of one-year mortality following hip fracture surgery in elderly
PeerJ
Albumin predicts 1-year mortality in humans (metastatic bladder cancer; albumin<35g/l) (Albumin<35 g/l: adjusted HR 3.06 (95% CI 1.81–5.17)).
“albumin<35g/l (aHR = 3.06 [1.81-5.17], P = 0.0001)”
Humansmetastatic bladder cancer; albumin<35g/l1 yearn = 180
Urologic oncology
Albumin is associated with 1-year mortality in humans (Preoperative measurement in patients undergoing hip fracture surgery) (OR 0.39, 95% CI 0.25–0.61).
“Low preoperative albumin and low body mass index predicted the 6-month and 1-year mortality.”
HumansPreoperative measurement in patients undergoing hip fracture surgery1 yearn = 772
Medicine
Albumin predicts 1-year mortality in humans (Albumin <3.3 g/dl after transcatheter aortic valve replacement).
“Home oxygen use, albumin levels <3.3 g/dl, falls in the past 6 months, STS PROM score >7%, and severe (≥5) Charlson comorbidity score predicted death at 1 year.”
HumansAlbumin <3.3 g/dl after transcatheter aortic valve replacement1 year
Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement
Journal of the American College of Cardiology
Cognitive impairment
downin humans5OR 0.082–0.95
5 studies
Cognitive impairment
downin humans5OR 0.082–0.95
Albumin is associated with cognitive impairment in humans (older adults with cognitive impairment) (OR = 0.53, 95% CI: 0.29–0.97).
“albumin was associated with reduced odds of cognitive impairment (OR = 0.53, 95% CI: 0.29–0.97)”
Humansolder adults with cognitive impairmentserumn = 438
AAIC 2025 abstract
Albumin is associated with cognitive impairment in humans (shared metabolite) (OR = 0.95 [0.92-0.98]).
“Albumin was identified as the common metabolite shared by the two phenotypes (OR = 0.90[0.85-0.95] for VI, and 0.95[0.92-0.98]) for cognitive impairment).”
Humansshared metaboliten = 23,775
Distinct and Overlapping Metabolites Associated with Visual Impairment and Cognitive Impairment
Journal of Alzheimer's disease reports
Albumin is linked with a lower risk of cognitive impairment in humans (OR = 0.37, 95% CI = 0.15, 0.88).
“albumin (OR = 0.37, 95% CI = 0.15, 0.88)”
Humansn = 4,578
The factors associated with cognitive function among community-dwelling older adults in Taiwan
BMC geriatrics
Albumin is associated with cognitive impairment in humans (older patients with severe aortic stenosis) (OR 0.082, p = 0.011).
“Prevalence of cognitive impairment of 15.3%, which was associated with albumin level - odds ratio (OR): 0.082; p = 0.011”
Humansolder patients with severe aortic stenosisn = 300
Revista de neurologia
Albumin is associated with cognitive impairment in humans (chronic heart failure) (OR 0.59 (0.35–0.99)).
“albumin > 3.5 (OR: 0.59 (0.35-0.99) p = 0.048)”
Humanschronic heart failuren = 525
BMC cardiovascular disorders
In-hospital mortality
downin humans3upin humans1OR 0.75–3.92
4 studies
In-hospital mortality
downin humans3upin humans1OR 0.75–3.92
Albumin predicts in-hospital mortality in humans (emergency surgery for perforated peptic ulcer) (OR 0.75).
“advanced age (odds ratio [OR] 1.07, p=0.010) and low serum albumin (OR 0.75, p<0.001) were the strongest independent predictors of mortality.”
Humansemergency surgery for perforated peptic ulcern = 97
A multidimensional approach to frailty in emergency surgery for perforated peptic ulcer
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES
Albumin predicts in-hospital mortality in humans (hospitalized nonagenarians).
“Equally, decreased albumin level was found to be a mortality predictor.”
Humanshospitalized nonagenarians
Clinical interventions in aging
Albumin is associated with in-hospital mortality in humans (Acute heart failure; multivariate analysis).
“and was independently associated with higher serum creatinine levels and lower serum albumin and TC levels.”
HumansAcute heart failure; multivariate analysisDuring hospitalizationn = 301
Revista espanola de geriatria y gerontologia
Albumin is associated with in-hospital mortality in humans (Patients requiring prolonged mechanical ventilation; albumin ≤2 g/dL) (OR 3.92, 95% CI 2.17–7.01 for albumin ≤2 g/dL).
“poor outcomes in this specific population were found to be associated with a higher APACHE II score and lower albumin level.”
HumansPatients requiring prolonged mechanical ventilation; albumin ≤2 g/dLn = 510
Medicine
Activities of daily living
upin humans1no changein humans1downin humans1
3 studies
Activities of daily living
upin humans1no changein humans1downin humans1
Albumin is associated with activities of daily living in humans (one month after admission).
“One month after admission, CONUT (correlation coefficient (r) = -0.587, confidence interval (CI) = -0.813 to -0.209) and Alb (r = 0.505, CI = 0.093 to 0.769) showed correlations with FIM improvement.”
Humansone month after admissionn = 21
Cureus
Albumin is associated with activities of daily living in humans (older patients with CKD in the acute phase) (ρ = 0.093, 95% CI -0.12 to 0.30, P = 0.384).
“albumin (ρ = 0.093; 95% CI, - 0.12 to 0.30; P = 0.384) and CRP level (ρ = - 0.176; 95% CI; - 0.37 to 0.03; P = 0.098) were not significantly correlated with the FIM score at discharge”
Humansolder patients with CKD in the acute phasen = 89
International urology and nephrology
Albumin is associated with activities of daily living in humans (patients admitted to geriatric rehabilitation after acute hospitalization).
“Lower average albumin, higher albumin variation and lower minimum albumin were associated with larger declines in ADL”
Humanspatients admitted to geriatric rehabilitation after acute hospitalization56% femalesn = 1,769
European geriatric medicine
Cognitive impairment
downin humans2upin humans1OR 0.6–1.023
3 studies
Cognitive impairment
downin humans2upin humans1OR 0.6–1.023
Albumin is linked with a lower risk of cognitive impairment in humans after adjusting for potential confounders (OR 0.60, 95% CI 0.41-0.87).
“a negative association was found between albumin levels and cognitive function (odds ratio [OR] = 0.60, 95% confidence interval [CI] 0.41-0.87).”
Humansafter adjusting for potential confounders
Sex and race differences in the association of albumin with cognitive function in older adults
Brain and behavior
Albumin is associated with cognitive impairment in humans (binary logistic regression) (OR = 1.023, 95%CI: 1.004-1.043, p = 0.011).
“Binary logistic regression showed that cognitive impairment was significantly associated with age (OR = 0.934, 95%CI: 0.886-0.985, p = 0.017), female sex (OR = 2.255, 95%CI: 1.761-2.888, p < 0.001), lower education level (less than senior high school) (OR = 11.509, 95%CI: 9.064-14.613, p < 0.001), and lower albumin (OR = 1.023, 95%CI: 1.004-1.043, p = 0.011).”
Humansbinary logistic regressionn = 7,201
Frontiers in aging neuroscience
Albumin is linked with a lower risk of cognitive impairment in humans (chronic heart failure) (OR = 0.767, P < 0.05).
“albumin (odds ratio [OR]=0.767, P < 0.05)”
Humanschronic heart failuren = 184
Research SquarePreprint
Malnutrition
downin humans2OR 0.07
2 studies
Malnutrition
downin humans2OR 0.07
Malnutrition is associated with albumin in humans (malnutrition or its risk (MNA ≤ 11)) (p < 0.001).
“lower levels of albumin, total protein, hemoglobin, leptin, 25(OH) D, and IGF-1, and higher levels of C-reactive protein (CRP), NT-proBNP, and ferritin (p < 0.001)”
Humansmalnutrition or its risk (MNA ≤ 11)n = 3,869
Clinical and Laboratory Markers of Body Wasting and Malnutrition in Long-Livers
Russian Journal of Geriatric Medicine
Albumin is linked with a lower risk of malnutrition in humans (nursing home residents) (OR = 0.070).
“The frailty risk (OR = 3.317), MM (OR = 0.732), PhA (OR = 0.033), serum albumin (OR = 0.070), and EuroQol visual analogue scale (OR = 0.961) were risk predictors of DRM”
Humansnursing home residentsn = 340
Nutrients
Cognitive function
upin humans2
2 studies
Cognitive function
upin humans2
Albumin is associated with cognitive function in humans (older adults with cognitive impairment) (β = 1.74, p = 0.045).
“albumin levels (β = 1.74, p = 0.045) were positively associated with MMSE scores”
Humansolder adults with cognitive impairmentserumn = 438
AAIC 2025 abstract
Albumin is associated with cognitive function in humans (participants aged 80 years).
“Nutritional status indicators such as serum albumin and frequency of going outdoors were significantly associated with cognitive functioning at age 80 years.”
Humansparticipants aged 80 years
Hypertension research : official journal of the Japanese Society of Hypertension
Intrinsic capacity
upin humans1
1 study
Intrinsic capacity
upin humans1
Albumin is associated with intrinsic capacity in humans (35.1; 95% CI 23.1-47.2).
“Changes in NLR, FAI, and serum levels of albumin, DHEA-S, vitamin D were associated with changes in IC over time”
Human trial12 months
Journal of the American Medical Directors Association
Decreased muscle thickness
upin humans1OR 7.08
1 study
Decreased muscle thickness
upin humans1OR 7.08
Albumin predicts decreased muscle thickness in humans (low (< 4.1 g/dL) versus normal (≥ 4.1 g/dL) serum albumin) (OR 7.08).
“participants in the low serum Alb group had an odds ratio of 7.08 for decreased muscle thickness at the AT.”
Human triallow (< 4.1 g/dL) versus normal (≥ 4.1 g/dL) serum albuminthigh12 weeksn = 69
BMC geriatrics
All 126Fewer
Funding
4 grants since 2019National Institute on Aging$666KJapan Society for the Promotion of Science¥8.8M
Japan Society for the Promotion of ScienceToho University¥4.4M2026–2029
Albumin hitchhiking siRNAs for gene targeting in aged brain
National Institute on AgingVanderbilt University$190K2022–2025
Fibrinogen coated albumin spheres to accelerate bone healing in older adults.
National Institute on AgingFibroplate$247K2021–2023
Role of albumin in muscle protein synthesis
Japan Society for the Promotion of ScienceShigakukan University¥4.4M2019–2022
How this record changed
Summary rewritten as its findings changed.
As it read before
Human studies link lower albumin to higher mortality and greater frailty in older and hospitalized adults, and associate it with walking speed and muscle mass. Human trials report increases with nutritional support and resistance training, decreases with caloric restriction in women, and no change with multicomponent exercise plus branched-chain amino acids.
Summary rewritten as its findings changed.
As it read before
Human studies report increased albumin with GLP-1 receptor agonists over 12 months and tirzepatide over 24 weeks in people with type 2 diabetes. A human study associates albumin with mortality following fragility fracture of the pelvis.
Summary written from the findings.